
A new treatment which could “transform” the lives of patients with severe asthma is to be approved for NHS use.
Tezepelumab, which is known as a biologic medicine, could be offered to up to 60,000 people in England.

A new treatment which could “transform” the lives of patients with severe asthma is to be approved for NHS use.
Tezepelumab, which is known as a biologic medicine, could be offered to up to 60,000 people in England.